 | • レポートコード：QYR9ST03823 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、基底細胞癌治療の世界市場について調査・分析し、基底細胞癌治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（手術、放射線療法、光線力学療法、薬）、用途別（小売薬局、病院薬局、癌研究所）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の基底細胞癌治療市場動向 ・主要企業別マーケットシェア ・基底細胞癌治療の種類別市場規模2014-2019 （手術、放射線療法、光線力学療法、薬） ・基底細胞癌治療の用途別市場規模2014-2019 （小売薬局、病院薬局、癌研究所） ・基底細胞癌治療の北米市場：主要企業・種類別/用途別市場規模 ・基底細胞癌治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・基底細胞癌治療の中国市場：主要企業・種類別/用途別市場規模 ・基底細胞癌治療の日本国内市場：主要企業・種類別/用途別市場規模 ・基底細胞癌治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・基底細胞癌治療のインド市場：主要企業・種類別/用途別市場規模 ・基底細胞癌治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Sun Pharmaceuticals、Valeant Pharmaceuticals International、Mylan、F. Hoffmann-La Roche、Merck） ・基底細胞癌治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening by metastasis only in extremely rare cases. According to the American Cancer Society, BCCs constitute around 80% of all non-melanoma skin cancers. Australia has been found to have the highest rate of basal cell carcinoma across the globe. Exposure to ultraviolet radiation is considered as the major cause behind BCC. Use of immunosuppressant drugs further enhance the chances of BCC as the immune system is compromised. White people are more vulnerable to BCC comparatively, according to a research published in the British Medical Journal. The symptoms of BCCs include waxy papules (slightly transparent bump) with pearly appearance and central depression and bleeding from the papules.The increase in geriatric population, giving rise to numerous skin diseases, such as actinic keratosis and other non-melanoma skin malignancies, is another important factor that has been fueling the demand for basal cell carcinoma treatment substantially. In addition to these, the market is expected to gain considerably from the changing lifestyle of people in developing economies over the coming years as it is anticipated to drive demand for better disease treatments, which in turn, is likely to provide lucrative opportunities for the companies operating in the global basal cell carcinoma treatment market.
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are considered as the prominent geographical segments of this market. North America, which is the current market leader, is expected to remain dominant over the next few years. The presence of a well-established medical and healthcare infrastructure, increasing expenditure on healthcare, and the high prevalence of basal cell carcinoma in this region are likely to boost the growth of the market for basal cell carcinoma treatment in North America.
In 2018, the global Basal Cell Carcinoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Basal Cell Carcinoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Basal Cell Carcinoma Therapeutics development in United States, Europe and China.
The key players covered in this study
Sun Pharmaceuticals
Valeant Pharmaceuticals International
Mylan
F. Hoffmann-La Roche
Merck
…
Market segment by Type, the product can be split into
Surgery
Radiation Therapy
Photodynamic Therapy
Drugs
Market segment by Application, split into
Retail Pharmacies
Hospitals Pharmacies
Cancer Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Basal Cell Carcinoma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Basal Cell Carcinoma Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Basal Cell Carcinoma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Basal Cell Carcinoma Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Radiation Therapy
1.4.4 Photodynamic Therapy
1.4.5 Drugs
1.5 Market by Application
1.5.1 Global Basal Cell Carcinoma Therapeutics Market Share by Application (2014-2025)
1.5.2 Retail Pharmacies
1.5.3 Hospitals Pharmacies
1.5.4 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Basal Cell Carcinoma Therapeutics Market Size
2.2 Basal Cell Carcinoma Therapeutics Growth Trends by Regions
2.2.1 Basal Cell Carcinoma Therapeutics Market Size by Regions (2014-2025)
2.2.2 Basal Cell Carcinoma Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Basal Cell Carcinoma Therapeutics Market Size by Manufacturers
3.1.1 Global Basal Cell Carcinoma Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Basal Cell Carcinoma Therapeutics Key Players Head office and Area Served
3.3 Key Players Basal Cell Carcinoma Therapeutics Product/Solution/Service
3.4 Date of Enter into Basal Cell Carcinoma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Basal Cell Carcinoma Therapeutics Market Size by Type (2014-2019)
4.2 Global Basal Cell Carcinoma Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Basal Cell Carcinoma Therapeutics Market Size (2014-2019)
5.2 Basal Cell Carcinoma Therapeutics Key Players in United States
5.3 United States Basal Cell Carcinoma Therapeutics Market Size by Type
5.4 United States Basal Cell Carcinoma Therapeutics Market Size by Application
6 Europe
6.1 Europe Basal Cell Carcinoma Therapeutics Market Size (2014-2019)
6.2 Basal Cell Carcinoma Therapeutics Key Players in Europe
6.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Type
6.4 Europe Basal Cell Carcinoma Therapeutics Market Size by Application
7 China
7.1 China Basal Cell Carcinoma Therapeutics Market Size (2014-2019)
7.2 Basal Cell Carcinoma Therapeutics Key Players in China
7.3 China Basal Cell Carcinoma Therapeutics Market Size by Type
7.4 China Basal Cell Carcinoma Therapeutics Market Size by Application
8 Japan
8.1 Japan Basal Cell Carcinoma Therapeutics Market Size (2014-2019)
8.2 Basal Cell Carcinoma Therapeutics Key Players in Japan
8.3 Japan Basal Cell Carcinoma Therapeutics Market Size by Type
8.4 Japan Basal Cell Carcinoma Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size (2014-2019)
9.2 Basal Cell Carcinoma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Type
9.4 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Application
10 India
10.1 India Basal Cell Carcinoma Therapeutics Market Size (2014-2019)
10.2 Basal Cell Carcinoma Therapeutics Key Players in India
10.3 India Basal Cell Carcinoma Therapeutics Market Size by Type
10.4 India Basal Cell Carcinoma Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Basal Cell Carcinoma Therapeutics Market Size (2014-2019)
11.2 Basal Cell Carcinoma Therapeutics Key Players in Central & South America
11.3 Central & South America Basal Cell Carcinoma Therapeutics Market Size by Type
11.4 Central & South America Basal Cell Carcinoma Therapeutics Market Size by Application
12 International Players Profiles
12.1 Sun Pharmaceuticals
12.1.1 Sun Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Basal Cell Carcinoma Therapeutics Introduction
12.1.4 Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Therapeutics Business (2014-2019)
12.1.5 Sun Pharmaceuticals Recent Development
12.2 Valeant Pharmaceuticals International
12.2.1 Valeant Pharmaceuticals International Company Details
12.2.2 Company Description and Business Overview
12.2.3 Basal Cell Carcinoma Therapeutics Introduction
12.2.4 Valeant Pharmaceuticals International Revenue in Basal Cell Carcinoma Therapeutics Business (2014-2019)
12.2.5 Valeant Pharmaceuticals International Recent Development
12.3 Mylan
12.3.1 Mylan Company Details
12.3.2 Company Description and Business Overview
12.3.3 Basal Cell Carcinoma Therapeutics Introduction
12.3.4 Mylan Revenue in Basal Cell Carcinoma Therapeutics Business (2014-2019)
12.3.5 Mylan Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Basal Cell Carcinoma Therapeutics Introduction
12.4.4 F. Hoffmann-La Roche Revenue in Basal Cell Carcinoma Therapeutics Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Basal Cell Carcinoma Therapeutics Introduction
12.5.4 Merck Revenue in Basal Cell Carcinoma Therapeutics Business (2014-2019)
12.5.5 Merck Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Basal Cell Carcinoma Therapeutics Key Market Segments
Table Key Players Basal Cell Carcinoma Therapeutics Covered
Table Global Basal Cell Carcinoma Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Basal Cell Carcinoma Therapeutics Market Size Market Share by Type 2014-2025
Figure Surgery Figures
Table Key Players of Surgery
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Photodynamic Therapy Figures
Table Key Players of Photodynamic Therapy
Figure Drugs Figures
Table Key Players of Drugs
Table Global Basal Cell Carcinoma Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Retail Pharmacies Case Studies
Figure Hospitals Pharmacies Case Studies
Figure Cancer Research Institutes Case Studies
Figure Basal Cell Carcinoma Therapeutics Report Years Considered
Table Global Basal Cell Carcinoma Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Basal Cell Carcinoma Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Basal Cell Carcinoma Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Basal Cell Carcinoma Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Basal Cell Carcinoma Therapeutics Market Share by Regions 2014-2019
Figure Global Basal Cell Carcinoma Therapeutics Market Share by Regions 2014-2019
Figure Global Basal Cell Carcinoma Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Basal Cell Carcinoma Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Basal Cell Carcinoma Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Basal Cell Carcinoma Therapeutics Market Share by Manufacturers in 2018
Table Global Basal Cell Carcinoma Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Basal Cell Carcinoma Therapeutics Product/Solution/Service
Table Date of Enter into Basal Cell Carcinoma Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Basal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Basal Cell Carcinoma Therapeutics Market Size Share by Type (2014-2019)
Figure Global Basal Cell Carcinoma Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Basal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Basal Cell Carcinoma Therapeutics Market Size Share by Application (2014-2019)
Figure Global Basal Cell Carcinoma Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Application in 2018
Figure United States Basal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Basal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Basal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table United States Basal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Basal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table United States Basal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Basal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure Europe Basal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Basal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Basal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Basal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Basal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure China Basal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Basal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Basal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table China Basal Cell Carcinoma Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Basal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table China Basal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Basal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure Japan Basal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Basal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Basal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table Japan Basal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Basal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table Japan Basal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Basal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Basal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Basal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Basal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Basal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Basal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure India Basal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Basal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Basal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table India Basal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Basal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table India Basal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Basal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Basal Cell Carcinoma Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Basal Cell Carcinoma Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Basal Cell Carcinoma Therapeutics Market Share (2018-2019)
Table Central & South America Basal Cell Carcinoma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Basal Cell Carcinoma Therapeutics Market Share by Type (2014-2019)
Table Central & South America Basal Cell Carcinoma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Basal Cell Carcinoma Therapeutics Market Share by Application (2014-2019)
Table Sun Pharmaceuticals Company Details
Table Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Therapeutics Business (2014-2019) (Million US$)
Figure Sun Pharmaceuticals Revenue Growth Rate in Basal Cell Carcinoma Therapeutics Business (2014-2019)
Table Sun Pharmaceuticals Recent Development
Table Valeant Pharmaceuticals International Company Details
Table Valeant Pharmaceuticals International Revenue in Basal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Valeant Pharmaceuticals International Revenue Growth Rate in Basal Cell Carcinoma Therapeutics Business (2014-2019)
Table Valeant Pharmaceuticals International Recent Development
Table Mylan Company Details
Table Mylan Revenue in Basal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Basal Cell Carcinoma Therapeutics Business (2014-2019)
Table Mylan Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Basal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Basal Cell Carcinoma Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Merck Company Details
Table Merck Revenue in Basal Cell Carcinoma Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Basal Cell Carcinoma Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Global Basal Cell Carcinoma Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Basal Cell Carcinoma Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Basal Cell Carcinoma Therapeutics Market Size Share by Regions in 2025
Figure United States Basal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Basal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Basal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Basal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Basal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Basal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Basal Cell Carcinoma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Basal Cell Carcinoma Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Basal Cell Carcinoma Therapeutics Market Size by Product (2019-2025)
Figure Global Basal Cell Carcinoma Therapeutics Market Size by Product in 2025
Table Global Basal Cell Carcinoma Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Basal Cell Carcinoma Therapeutics Market Size by Application (2019-2025)
Figure Global Basal Cell Carcinoma Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
進行腎細胞癌治療薬の世界市場：市場規模・現状・予測 Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell …- 多発性骨髄腫用るCAR T細胞療法の世界市場：市場規模・現状・予測 CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- 犬幹細胞療法の世界市場：市場規模・現状・予測 The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- 多発性硬化症向け幹細胞療法の世界市場：市場規模・現状・予測 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 非小細胞肺癌治療薬の世界市場：市場規模・現状・予測 Lung cancer or lung carcinoma is a disease characterized by uncontrolled cell growth in the lungs. Common symptoms include cough, chest pain, weight loss, and shortness of breath. Due an increase in the incidence of lung cancer, the global lung cancer therapeutics market is expected to expand at a r…